1R Jeffrey Change,Seth E Katz.Polycystic ovary syndrome[J].Endocrinol Metal Clin North Am,1999,28(2):397-408. 被引量：1
2Cordon CM.Menstrual disorders in adolescents.Excess androgens and the polycystic ovary syndrome[J].Pediatr Clin North Am,1999,46(3):519-543. 被引量：1
3Marshall JC,Eagleson CA.Neuroendocrine aspects of ovary syndrome[J].Endocrinol & Metab Clin North Am,1999,28(2):295-324. 被引量：1
4Diamanti-Kandarakis E,Kouli C,Tsianateli T,et al.Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome[J].Eur J Endocrinol,1998,138(3):269-274. 被引量：1
5Moghetti P,Castello R,Negri C,et al.Metfomin effects on clinical features,endocrine and metabolic profiles,and insulin sensitivity in polycystic ovary syndrome:a randomized,double-blind placebo-controlle 6-month trial,followed by open,long-term clinical evaluation[J].J Clin Endocrinol Metab,2000,85(1):139-146. 被引量：1
9Carmina E.Dignosis of polycystic ovary syndrome:from NIH criteria to ESHRE-ASRM guidelines[J].Minerva Ginecol,2004,56(1):126. 被引量：1
10Trolle B,Flyvbjerg A,Kesmodel U,et al.Efficacy of metform in obese and non-obese women with polycystic ovary syndrome:A random ized,double-blinded,Plaeebo-controlled cross-over trial[J].Hum Repord,2007,22(11):2967-2973. 被引量：1
